Spectral Medical Inc.
EDTXF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 7.22 | -0.23 | -0.44 | 0.58 |
| FCF Yield | -6.33% | -9.15% | -10.17% | -16.35% |
| EV / EBITDA | -12.68 | -8.94 | -12.49 | -7.51 |
| Quality | ||||
| ROIC | 158.46% | 329.44% | -109.81% | -91.37% |
| Gross Margin | 44.53% | 41.43% | 58.97% | 59.45% |
| Cash Conversion Ratio | 0.57 | 0.68 | 0.88 | 0.99 |
| Growth | ||||
| Revenue 3-Year CAGR | 11.10% | -8.00% | -7.42% | -10.56% |
| Free Cash Flow Growth | 18.90% | -9.49% | -8.46% | -1,337.25% |
| Safety | ||||
| Net Debt / EBITDA | -1.00 | -0.40 | 0.23 | 1.30 |
| Interest Coverage | -3.78 | -11.47 | -53.64 | -307.18 |
| Efficiency | ||||
| Inventory Turnover | 5.54 | 2.56 | 2.01 | 2.84 |
| Cash Conversion Cycle | -147.05 | -437.16 | -509.87 | -29.78 |